BindingDB logo
myBDB logout

null

SMILES: Brc1ccccc1N1CCC(CC1)C(=O)Nc1ccc2OCC(=O)Nc2c1

InChI Key: InChIKey=JKYZWCDVAWOHQP-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50272900   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Transient receptor potential cation channel subfamily V member 1


(Homo sapiens (Human))
BDBM50272900
PNG
(1-(2-bromophenyl)-N-(3-oxo-3,4-dihydro-2H-benzo[b]...)
Show SMILES Brc1ccccc1N1CCC(CC1)C(=O)Nc1ccc2OCC(=O)Nc2c1
Show InChI InChI=1S/C20H20BrN3O3/c21-15-3-1-2-4-17(15)24-9-7-13(8-10-24)20(26)22-14-5-6-18-16(11-14)23-19(25)12-27-18/h1-6,11,13H,7-10,12H2,(H,22,26)(H,23,25)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
71n/an/an/an/an/an/an/an/a



Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL


Assay Description
Displacement of [3H]RTX from human TRPV1 receptor expressed in HEK293 cell membrane


Bioorg Med Chem Lett 18: 4569-72 (2008)


Article DOI: 10.1016/j.bmcl.2008.07.035
BindingDB Entry DOI: 10.7270/Q2154GV5
More data for this
Ligand-Target Pair
Transient receptor potential cation channel subfamily V member 1


(Homo sapiens (Human))
BDBM50272900
PNG
(1-(2-bromophenyl)-N-(3-oxo-3,4-dihydro-2H-benzo[b]...)
Show SMILES Brc1ccccc1N1CCC(CC1)C(=O)Nc1ccc2OCC(=O)Nc2c1
Show InChI InChI=1S/C20H20BrN3O3/c21-15-3-1-2-4-17(15)24-9-7-13(8-10-24)20(26)22-14-5-6-18-16(11-14)23-19(25)12-27-18/h1-6,11,13H,7-10,12H2,(H,22,26)(H,23,25)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 160n/an/an/an/an/an/a



Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL


Assay Description
Antagonist activity at human TRPV1 receptor assessed as inhibition of capsaicin-induced calcium flux by FLIPR


Bioorg Med Chem Lett 18: 4569-72 (2008)


Article DOI: 10.1016/j.bmcl.2008.07.035
BindingDB Entry DOI: 10.7270/Q2154GV5
More data for this
Ligand-Target Pair